Searched for
DABUR OPEN OFFER
India Inc gears up for Middle East rebound after peace dealIndian businesses are preparing for a surge in Middle East demand following a peace agreement. Companies are increasing production and secu...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...
- Narendra Solanki sees limited IT growth, bets on rural and pharma playsInvestors are becoming selective, focusing on earnings visibility and strong balance sheets. Opportunities are emerging in sectors like IT,...
- Burmans raise stake in Religare to 30% via open market purchasesThe Burman family is making waves in the financial sector by increasing their stake in Religare Enterprises to roughly 30%. This strategic ...
- Delhi High Court allows Burman family's open offer for ReligareThe Delhi High Court has allowed the Burman family's open offer for acquiring a stake in Religare Enterprises Ltd to proceed, despite appea...
- Burmans' Religare open offer to acquire additional 26% stake to start on Jan 27Burman family's open offer to acquire 26% additional stake in Religare Enterprises Ltd begins on January 27. The offer targets 9 crore shar...
- ED summons Dabur chief Mohit Burman, others for money laundering probe in Religare open offer caseThe Enforcement Directorate (ED) has summoned Dabur India chairman Mohit Burman and three independent directors from Care Health Insurance ...
- Sebi orders Religare to apply for open offer before July 12Sebi directs Religare Enterprises to obtain approvals from all regulators by July 12 for Burman family's open offer to buy more shares. The...
- Timing of Burmans' open offer fishy: Religare independent director Hamid Ahmed"The merits of the offer are not very good. They want to replace the board and the management," said Ahmed, also the chief executive office...
- Dabur's open offer price for Religare is fair: Mohit BurmanOnce the open offer is concluded, the Burman family-owned entities - currently the largest shareholding bloc at Religare - will nominate th...
- Burman family announces Rs 2,116 crore open offer for 26% stake in Religare EnterprisesMB Finmart, Puran Associates, VIC Enterprises and Milky Investment & Trading Company are the entities that will participate in the open off...
- 3 Burman family nominees, including Anand Burman appointed on Eveready boardThe Burman Group, through its entities Puran Associates, VIC Enterprises, MB Finmart, Gyan Enterprises and Chowdry Associates had increased...
- Eveready Industries Chairman, MD resign amid Burman Group's takeover bidThe resignations of Aditya Khaitan and Amritanshu Khaitan come two days after the Burmans of Dabur group made an open offer for the Kolkata...
- Dabur promoters make open offer for Eveready Industries takeover bidThe mandatory open offer under the takeover regulations of SEBI was made as the Burmans acquired an additional 5.26 per cent stake of Evere...
- Dabur acquires Turkey's Hobi Kozmetik for Rs 324 croreMaking its first ever overseas acquisition, FMCG player Dabur today said it has acquired Turkish personal care firm Hobi Kozmetik Group for...
- Dabur Pharma gets Government nod for name changeDabur Pharma on Tuesday said it has received the government's approval for changing its name to Fresenius Kabi Oncology.
- Open offer to Dabur Pharma shareholders rescheduledDabur Pharma on Tuesday said the open offer to its shareholders by German firm Fresenius Kabi has been rescheduled and will now begin on Ju...
- Fresenius Kabi makes open offer to buy 20% of Dabur PharmaFresenius Kabi, an arm of German healthcare group Fresenius SE, on Wednesday made an open offer to buy an additional 20 per cent in Burman ...
- Fresenius Kabi to invest $70 mn, announces open offerDays after acquiring 73.3 per cent control of Dabur Pharma, European health care firm Fresenius Kabi on Monday said it would launch a publi...
- Dabur Pharma's new owner launches open offerEuropean health care firm Fresenius Kabi, which acquired 73.3 per cent control of Dabur Pharma last week, today announced a public offer to...
Load More
